Vascular Web Logo

SVS  SVS Foundation

 Thursday, June 5th

All events take place in the Hynes Convention Center unless otherwise noted.

6:00 a.m. – 6:00 p.m .
6:30 a.m. – 8:00 a.m.
B1: Hemodialysis Access: Challenges and Breakthroughs, Ballroom C, Level 3 
At the end of this session, participants should be able to:
  1. Identify the factors affecting vein diameter on ultrasound
  2. Describe endovascular options for fistula salvage
  3. Describe how aneurysmal degeneration of AVFs can be treated
  4. Identify the utility of ultrasound in fistula maintenance
  5. Explain the options of dialysis access available for the morbidly obese
  6. Describe new technology for dialysis access
Moderators: Niten Singh, MD, University of Washington, Seattle, WA
Eric K. Peden, MD, The Methodist Hospital, Houston, TX

6:30 am
Fistula First- When is the Vein Too Small for an AVF
Niten Singh, MD, University of Washington, Seattle, WA

6:40 am
Endovascular Salvage of the Failing Fistula
George H Meier, MD RVT FACS, University of Cincinnati School of Medicine, Cincinnati, OH

6:50 am
Treatment of Fistula Aneurysms
Eric K. Peden, MD, The Methodist Hospital, Houston, TX

7:00 am 
Point of Care Ultrasound- How I Use This in My Practice 
Gale L. Tang, MD FACS, University of Washington, Seattle, WA

7:10 am
Dialysis Access in the Morbidly Obese Patient
William C. Jennings, MD, University of Oklahoma College of Medicine, Tulsa, OK 

7:20 am
Emerging Technology beyond the Conventional Graft
Jeffery H. Lawson, MD, Duke University Medical Center, Durham, NC

Panel Discussion/Questions
B2: Changing Paradigms in Asymptomatic Carotid Disease, Room 304/306
Moderators:   Manish Mehta MD, the Institute for Vascular Health and Disease, Albany Medical College, Albany, NY
Mark K. Eskandari MD, Northwestern University Feinberg School of Medicine, Chicago, IL
William J. Quinones-Baldrich MD, University of California, Los Angeles, CA

6:30 am
How advanced imaging might shape our ability to manage asymptomatic Carotid Stenosis patients 
Ali F. AbuRahma MD, West Virginia University Charleston Division, Charleston, WV

6:38 am
Tandem Asymptomatic Proximal Common Carotid or Innominate Lesions during CEA or CAS - When to treat and how?
Saum A. Rahimi MD, Rutgers – Robert Wood Johnson Medical School, New Brunswick, NJ

6:46 am
CEA Techniques that Matter
Philip S.K. Paty MD, the Vascular Group, Albany, NY

6:54 am
Transcervical carotid stenting with flow reversal for cerebral protectionRoadster Flow Reversal with Carotid Cut-down 
Enrique Criado MD PhD, Vascular Surgery, University of Michigan, Ann Arbor, MI

7:02 am
Asymptomatic Carotid Dissections - Imaging and treatment 
Robert Y. Rhee MD, Maimonides Medical Center, Brooklyn, NY
7:10 am
ACT 1 Update  
Jon S. Matsumara MD, University of Wisconsin School of Medicine and Public Health, Madison, WI
7:18 am
Crest 2 Design - Will it find the Answers?
Wesley S. Moore MD, Division of Vascular Surgery, UCLA, Los Angeles, CA

7:26 am
Panel Discussion 
B3: Post EVAR Management: Surveillance Endoleaks and When to Intervene, Room 302  
At the end of this session, participants should be able to:
  1. Evaluate the risk of rupture after EVAR
  2. Assess and apply different strategies of follow-up after EVAR according to preoperative, operative and postoperative risk factors and imaging findings
  3. Develop methods for surveillance after EVAR 
  4. Identify endovascular treatment modalities for different types of endoleaks
  5. Explain how to approach and treat persistent type II endoleaks and type I endoleaks
Moderators: Peter A. Schneider MD, Kaiser Permanente Medical Group, Honolulu, HI
Carlos H. Timaran MD, University of Texas Southwestern Medical School, Dallas, TX
6:30 am
6:35 am
What do we know so far about Post-EVAR rupture? Can it be Prevented?
Charles W. Sternbergh MD, Ochsner Clinic Foundation, New Orleans, LA

6:47 am 
Post-EVAR Surveillance: How often, by what Modality, is it forever and Tips for Following High Risk Groups?
Rabih A. Chaer MD, University of Pittsburg, Pittsburg, PA

6:59 am
Which Endoleaks to Worry about and When to Intervene?
Bart E. Muhs MD, Yale University School of Medicine, New Haven, CT

7:11 am
Procedures for Treating Type II Endoleaks
Carlos H. Timaran MD, University of Texas Southwestern medical School, Dallas, TX

7:23 am 
Endovascular Treatment for Type I Endoleaks
Gustavo Oderich MD, Mayo Clinic, Rochester, MN

7:33 am
Panel Discussion
6:30 a.m. – 8:00 a.m.
General Surgery Resident Program Breakfast
(see Fellow/Resident/Student program for more details​​)
6:30 a.m. – 8:00 a.m.
Medical Student (MS1/MS2) Program Breakfast 
(see Fellow/Resident/Student program for more details​)
6:30 a.m. – 8:00 a.m.
Medical Student (MS3/MS4) Program Breakfast
(see Fellow/Resident/Student program for more details​)​
8:00 a.m. – 8:30 a.m.
Opening Ceremony, Ballroom A/B, Level 3
8:30 a.m. – 10:00 a.m.
S1: William J. von Liebig Forum, Ballroom A/B, Level 3
Moderators: Julie Ann Freischlag, MD, Ronald M. Fairman, MD


8:30 a.m.
SS1. Predictors and Outcomes of Endoleaks
Wei Zhou, Brajesh K. Lal, Ziyi Li, Tassos Kyriakides, Jon S. Matsumura, Frank Lederle, Julie Ann Freischlag

8:44 a.m
SS2. Staged Endovascular Repair of Thoraco-Abdominal Aneurysms (TAA) Protects Against Spinal Cord Injury
Adrian O’Callaghan, Matthew J. Eagleton, Tara M. Mastracci, James Bena

8:58 a.m.
VS1. 3D Fusion Overlay Imaging Is an Important Adjunct for Reducing Radiation Dose, Contrast Volume, and Surgery Time When Performing Fenestrated Endovascular Aneurysm Repair Andres Schanzer, Manuela Schuksz

9:08 a.m.
SS3. Factors Associated with Spinal Cord Ischemia After Multi-Branched Endovascular Thoracoabdominal Aneurysm Repair

Julia D. Sobel, Shant M. Vartanian, Warren J. Gasper, Marlene Grenon, Joseph H. Rapp, Jade S. Hiramoto, Timothy A.M. Chuter, Linda M. Reilly

9:22 a.m.
SS4. In Patients Stratified by Preoperative Risk, Endovascular Repair of Ruptured Abdominal Aortic Aneurysms Has a Lower In-Hospital Mortality and Morbidity than Does Open Repair Mujtaba Ali, Julie Flahive, Andres Schanzer, Jessica P. Simons, Francesco A. Aiello, Danielle Doucet, Louis M. Messina, William P. Robinson

9:36 a.m.
SS5. Antibodies Against Malondialdehyde-Acetaldehyde Adducts Can Identify Patients with Abdominal Aortic Aneurysm

Jeffrey S. Carson, Wanfen Xiong, Jennifer M. Worth, Trevor Meisinger, Matthew Dale, Fang Yu, Lynell W. Klassen, Michael J. Duryee, Carlos D. Hunter, Daniel R. Anderson, Geoffrey M. Thiele, Timothy Baxter

10:00 a.m. – 10:30 a.m.
E1: John Homans Lecture, Ballroom A/B, Level 3

Julie Ann Freischlag, MD

10:05 a.m.
Carotid Surgery “Trials and Tribulations” Wesley S. Moore, MD

10:30 a.m. – Noon
F1: E. Stanley Crawford Critical Issues Forum, Ballroom A/B, Level 3  
Appropriateness of Procedures for Vascular Disease: Is There a Problem?

At the end of this session, participants should be able to:
  1. Distinguish regional variations in vascular surgery procedures
  2. Explain the impact of industry on appropriateness of procedures and volume
  3. Determine who should perform vascular procedures by controlling variations in quality
  4. Explain how guidelines impact appropriateness and establish enforceable professional standards
  5. Compare ethical breaches in community practice and academic practice
Moderator: Peter F. Lawrence, MD, UCLA Medical Center, Los Angeles, CA
10:30 am
Peter F. Lawrence, MD, UCLA Medical Center, Los Angeles, CA

10:35 am
Data on Vascular Surgery Procedures
Robert M. Zwolak MD PhD, Dartmouth-Hitchcock Medical Center, Lebanon, NH
10:45 am
Optimizing Multi-Specialty Involvement in Vascular ProceduresSpecialty Variations In Vascular Procedures
Michael D. Dake MD, Stanford University Medical Center, Stanford, CA

10:55 am
Hospital/Physician Practice Organization Impact On Appropriateness
Timothy Ferris MD, Partners HealthCareMass General Physicians Organization, Boston MA

11:05 am
Practice Guidelines
Peter Gloviczki MD, Mayo Clinic, Rochester, MN

11:15 am
Ethical Issues Related To Frequency Of Procedures
Russell H. Samson MD, Mote Vascular Foundation and Sarasota Vascular Specialists, Sarasota, FL

11:25 am
Panel Discussion
12:00 PM - 1:00 PM, Exhibit Hall C Vascular Live Stage, Level 2
Vascular Live: A Discussion of Lutonix Drug Coated Ballroon Technology sponsored by Bard Peripheral Vascular, Inc., Elena Ladich, MD, Edward Woo, MD, and Patrick Geraghty, MD

12:00 PM - 12:30 PM, Exhibit Hall D Vascular Live Stage, Level 2
Vascular Live: From Creation to Revision: New Solutions for Dialysis Patients sponsored by Gore and Associates, Tom Vesely, MD

12:00 PM- 12:30 PM, Exhibit Hall D Vascular Live Stage, Level 2
Vascular Live: The Latest Solutions for Patients with PAD sponsored by Gore and Associates, Dennis Gable, MD, Richard Neville, MD
*Vascular Live presentations are not part of the ACCMEaccredited portion of the Vascular Annual Meeting.

Noon – 6:30 p.m.
Exhibit Hall Open
Noon – 1:20 p.m.
Lunch in Exhibit Hall C & D, Level 2
Noon – 6:30 p.m.
Poster Set Up
1:20 p.m. – 2:30 p.m.
S2: SVS Plenary Session II, Ballroom A/B, Level 3
Moderators: Peter F. Lawrence, MD, Manish Mehta, MD
1:20 p.m.
SS6. Natural History of Medically-Managed Acute Type B Aortic Dissections
Christopher A. Durham, Linda Wang,  Emel A. Ergul, Nathan J. Aranson,  Virendra I. Patel, Richard P. Cambria, Mark F. Conrad
1:34 p.m.
SS7. The Contemporary Guidelines for Asymptomatic Renal Artery Aneurysms Are Too Aggressive:  A North American Experience
Peter F. Lawrence, Jill Q. Klausner, Michael P. Harlander-Locke, James C. Stanley, Dawn M. Coleman, Gustavo S. Oderich, Robert Hye, Matthew W. Mell, William C. Pevec, David L. Dawson, Misty Humphries, Paul G. Bove, Christopher J. Abularrage, Robert J. Feezor, Amir F. Azarbal, Matthew R. Smeds, Joseph S. Ladowski, York N. Hsiang, Fred A. Weaver, Mark D. Morasch
1:48 p.m.
SS8. Contemporary Outcomes of Intact (iVAA) and Ruptured (rVAA) Visceral Artery Aneurysm Repair
Ankur J. Shukla,  Raymond Eid,  Larry Fish, Efthimios Avgerinos, Luke K. Marone, Michel S. Makaroun,  Rabih A. Chaer
2:02 p.m.
VS2. TEVAR, EVAR, Endovascular Septectomy, and Chimneys for Managing Complex Thoracoabdominal Aortic Dissection & Aneurysms
Manish Mehta, Pierre G. Silviera, Medhi J. Teymouri, Jeffrey C. Hnath, Chin Chin Yeh, Paul B. Kreienberg, Benjamin B. Chang, R. Clement Darling III
2:12 p.m.
SS9. Vascular Reconstruction Plays an Important Role in the Treatment of Pancreatic Adenocarcinoma
Michael D. Sgroi, Raja S. Narayan, John S. Lane, Aram N. Demirjian, Roy M. Fujitani, David K. Imagawa

2:30 p.m. – 3:00 p.m.
E2: Roy Greenberg Distinguished Lecture, Ballroom A/B, Level 3
2:30 p.m.
In Memoriam and Introduction Julie Ann Freischlag, MD
2:40 p.m.
New Horizons in Aortic Disease – The Lasting Legacy of a Visionary Innovator Gustavo S. Oderich, MD
3:30 p.m. - 4:00 p.m., Vascular Live Stage, Exhibit Hall C
Vascular Live: Managing Complex EVAR Cases with the Aptus Heli-FX EndoAnchor System sponsored by Aptus Endosystems, Inc., Bart Muhs, MD and William Jordan, MD
3:00 p.m. – 3:30 p.m.
3:30 p.m. – 4:00 p.m.
Coffee Break
4:00 p.m. – 5:30 p.m.
S3: SVS Plenary Session III, Ballroom A/B, Level 2
Moderators: Peter Gloviczki, MD, Amy B. Reed, MD
4:00 p.m.
SS10. Why Discordance of the Treatment Received Compared with the Treatment Recommended Results in Worse Outcomes for Peripheral Arterial Disease Thomas E. Brothers
4:14 p.m.
SS11. Geometric Remodeling of Vein Bypass Grafts and the Impact on Graft Failure Yong He, Kenneth Desart, Khayree Butle, Anne Irwin, Peter R. Nelson, Scott A. Berceli
4:28 p.m.
SS12. Prospective Analysis of Wound Characteristics and Degree of Ischemia on Time to Wound Healing and Limb Salvage: An Early Validation of the Society for Vascular Surgery Lower Extremity Threatened Limb Classification System
David L. Cull, Ginger Manos,  Michael Hartley, Spence M. Taylor, Eugene M. Langan,  John F. Eidt,  Brent L. Johnson
4:42 p.m.
SS13. Inflammation and Vascular Healing Christopher D. Owens
4:56 p.m.
VS3. Popliteal Venous Pseudoaneurysm and Associated Arteriovenous Fistula Following Knee Arthroscopy
Sachinder S. Hans, Marika Y. Gassner
5:06 p.m.
SS14. Endovascular Treatment of Common Femoral Artery Occlusive Disease in 167 Consecutive Patients: Midterm Analysis
Manish Mehta, Jeffrey C. Hnath, Max Kahn, Paul B. Kreienberg, Chin Chin Yeh, Melissa Shah, Paul Feustel, R. Clement Darling III
5:30 p.m. – 6:30p.m. 
Opening Reception, Exhibit Halls C/D, Level 2 
7:00 p.m. – 8:00 p.m.
Individual Alumni and Committee Receptions, Sheraton Boston Hotel 

Contact Us

Society for Vascular Surgery
633 North Saint Clair Street, 22nd Floor | Chicago, IL 60611
Phone: 312-334-2300 | 800-258-7188
Fax: 312-334-2320

Follow Us


VascularWeb® is the prime source for all vascular health and disease information, and is presented by the Society for Vascular Surgery®. Its members are vascular surgeons, specialists, and vascular health professionals who are specialty-trained in all treatments for vascular disease including medical management, non-invasive procedures, and surgery.